Costs and benefits of improving access to psychotherapies for common mental disorders

Journal of Mental Health Policy and Economics

Volumn 16, Issue 4, 2013, Pages

  Dezetter, Anne ^a,b   Briffault, Xavier ^b   Lakhdar, Christian Ben ^c   Kovess Masfety, Viviane ^a  

^a EHESP SCHOOL OF PUBLIC HEALTH   (France)

^b EHESS Sciences   (France)

^c UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; AGED; ANXIETY DISORDER; ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; COST OF ILLNESS; DEPRESSION; DISEASE SEVERITY; FEMALE; FRANCE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PSYCHOTHERAPIST; PSYCHOTHERAPY; QUALITY OF LIFE; REIMBURSEMENT; REMISSION; SHEEHAN DISABILITY SCALE; ADOLESCENT; ECONOMICS; HEALTH CARE DELIVERY; INSURANCE; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; FEMALE; FRANCE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MIDDLE AGED; PSYCHOTHERAPY; YOUNG ADULT;

EID: 84897019389     PISSN: 10914358     EISSN: 1099176X     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Roth A, Fonagy P. What works for whom: a critical review of psychotherapy research New York: Guilford, 2005.
2. Institut National de la Santé et de la Recherche Médicate. [Psychotherapy: Three approaches evaluated] (in French) Paris: INSERM, 2004.
3. Mumford E, Schlesinger HJ, Glass GV, Patrick C, Cuerdon T. A new look at evidence about reduced cost of medical utilization following mental health treatment. Am J Psychiatry 1984; 141: 1145-1158. (Pubitemid 14011484)
4. Gabbard GO, Lazar SG, Hornberger J, Spiegel D. The economic impact of psychotherapy: a review. Am J Psychiatry 1997; 154: 147-155. (Pubitemid 27053718)
5. de Maat S, Philipszoon F, Schoevers R, Dekker J, De Jonghe F. Costs and benefits of long-term psychoanalytic therapy: changes in health care use and work impairment. Harv Rev Psychiatry 15: 289-300, 2007.
6. Chiles JA, Lambert MJ. The Impact of Psychological Interventions on Medical Cost Offset: A Meta-analytic Review. Clinical Psychology Science and Practice 1999; 6: 204-220.
7. Myhr G, Payne K. Cost-effectiveness of cognitive-behavioural therapy for mental disorders: implications for public health care funding policy in Canada. Can J Psychiatry 2006; 51: 662-670. (Pubitemid 44526427)
8. Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004; 61: 1097-1103. (Pubitemid 39463410)
9. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 3rd ed. Washington DC: American Psychiatric Association, 2010.
10. Guidelines Advisory Committee. Psychological Therapy and Counseling. Ontario: Ministry of Health and Long-Term Care, the Ontario Medical Association, 2007.
11. Australian Institute of Health and Welfare (AIHW): Mental health services in Australia 2007-08 Canberra, Australian Government, Autralian Institute of Health and Welfare, 2010.
12. Centraal BegeleidingsOrgaan. [Multidisciplinary Guideline for Depression: Guideline for diagnosis and treatment of depressive disorder in adult patients 2005] (in Dutch) Utrecht: Trimbos-instituut Netherlands Institute of Mental Health and Addiction. Dutch Institute for Healthcare Improvement, Central Accompagnement Organization, 2005.
13. National Institute for Clinical Excellence. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. NICE clinical guideline 31 London: National Collaborating Centre for Mental Health, 2005.
14. National Institute for Clinical Excellence. Post-traumatic stress disorder (PTSD): the management of PTSD in adults and children in primary and secondary care. NICE clinical guideline 26 London: National Collaborating Centre for Mental Health, 2005.
15. National Institute for Clinical Excellence. The treatment and management of depression in adults. NICE clinical guideline 90 London: National Collaborating Centre for Mental Health, 2009.
16. National Institute for Clinical Excellence. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. NICE clinical guideline 113 London: National Collaborating Centre for Mental Health and the National Collaborating Centre for Primary Care, 2011.
17. Haute Autorité de Santé. Diagnostic et prise en charge en ambulatoire du trouble anxieux généralisé de l'adulte (in French) Paris: Recommandations Pour La Pratique Clinique, Haute Autorité de Santé, 2001.
18. Haute Autorité de Santé. Prise en charge d'un episode dépressif isolé de l'adulte en ambulatoire (in French) Paris: Recommandations pour la pratique clinique, Haute Autorite de Sante, 2002.
19. Clery-Melin P, Kovess V, Pascal JC: Plan d'actions pour le développement de la psychiatrie et la promotion de la santé mentale (in French) Paris: Ministère de la santé, de la famille et des personnes handicapées, 2003.
20. Briot M. [Report on the good use of psychotropic medicine] (in French) Paris: Office parlementaire d'évaluation des politiques de santé, Assemblée Nationale, 2006.
21. Couty E. Missions et organisation de la santé mentale et de la psychiatrie (in French) Paris: Ministère de la santé et des sports, 2009.
22. Dezetter A, Kovess V. [Epidemiological and socio-economic analysis of the situation of psychotherapies in France, with a view to proposals for reimbursement policies] (in French) Paris: Caisse Nationale d'Assurance Maladie des Travailleurs Salariés [French National Public Health Insurance for Employees], EA4069, Paris Descartes University, 2012.
23. th 2013)
24. Priebe S, Wright D. The provision of psychotherapy: an international comparison. Journal of Public Mental Health 2006; 5: 12-22.
25. Layard R. The case for psychological treatment centres. Bmj 2006; 332: 1030-1032. (Pubitemid 44365527)
26. Layard R, Clark D, Knapp M, Mayraz G. Implementing the NICE guidelines for depression and anxiety. A cost-benefit analysis London: Centre of Economic Performance, The London School of Economics and Political Science, 2006.
27. Layard R, Clark D, Knapp M, Mayraz G. Cost-Benefit Analysis of Psychological Therapy. Discussion Paper No 829 London: Centre for Economic Performance, 2007.
28. National Health Service. Improving Access to Psychological Therapies (1APT), Guidance for Commissioning IAPT Training 2011/12-2014/15 London: IAPT Programme, Department of Health, 2011.
29. Verdoux H. The current state of adult mental health care in France. Eur Arch Psychiatry Clin Neurosci; 257:64-70, 2007. (Pubitemid 46399215)
30. Dezetter A, Briffault X, Alonso J, Angermeyer MC, Bruffaerts R, de Girolamo G, De Graaf R, Haro JM, Konig HH, Kovess-Masféty V. Factors Associated With Use of Psychiatrists and Nonpsychiatrist Providers by ESEMeD Respondents in Six European Countries. Psychiatr Serv 62: 143-151, 2011.
31. Dezetter A, Briffault X, Bruffaerts R, De Graaf R, Alonso J, Konig HH, Haro JM, de Girolamo G, Vilagut G, Kovess-Masféty V. Use of general practitioners versus mental health professionals in six European countries: the decisive role of the organization of mental health care systems. Soc Psychiatry Psychiatr Epidemiol 48:137-149, 2013.
32. Kovess-Masféty V, Saragoussi D, Sevilla-Dedieu C, Gilbert F, Suchocka A, Arveiller N, Gasquet I, Younes N, Hardy-Bayle MC. What makes people decide who to turn to when faced with a mental health problem? Results from a French survey. BMC Public Health 2007; 7: 188.
33. Le Breton-Lerouvillois G, Gilbert F, Kovess-Masféty V. Les indicateurs nécessaires à la planification en santé mentale et en psychiatrie (in French) Paris: EA4069, Fondation MGEN pour la Santé Publique, Ministère de l'Emploi, de la cohésion sociale et du logement, 2007.
34. Briffault X, Morvan Y, Rouillon F, et al.: [Use of services and treatment adequacy of major depressive episodes in France] Encephale 2008; 36 Suppl 2: D48-58.
35. National Health Service. Impact Assessment of the expansion of Talking Therapies London: Department of Health, 2011.
36. th 2013)
37. Vasiliadis H-M, Drapeau M, Latimer E, Lesage A, Assessing the system level costs and benefits of improving equity in access to psychological services for depression in Canada. Canadian Institutes of Health Research, Operating grants, March 2012-February 2014, $180,180.
38. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC: American Psychiatric Association, 1994.
39. Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 1997; 27: 93-105. (Pubitemid 27407503)
40. Lambert M, Ogles B. 2004. The efficacy and effectiveness of psychotherapy. In Bergin and Garfield's Handbook of Psychotherapy and Behavior Change. New-York: John Wiley, 139-193.
41. Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, Wessely S. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technol Assess 2001; 5: 1-173.
42. Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry 2002; 159: 1354-1360. (Pubitemid 34832717)
43. Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo P. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry 1998; 55: 816-820. (Pubitemid 28413044)
44. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry 1999; 56: 829-835. (Pubitemid 29420704)
45. Roemer L, Orsillo SM, Salters-Pedneault K. Efficacy of an acceptance-based behavior therapy for generalized anxiety disorder: evaluation in a randomized controlled trial. J Consult Clin Psychol 2008; 76: 1083-1089.
46. McCrone P, Dhanasiri S, Patel A, Knapp M, Lawton-Smith S. Paying the price. The cost of mental health care in England to 2026 London: King's Fund, 2008.
47. Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA. Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 2002; 181: 208-213. (Pubitemid 34983527)
48. Krueger RF, Markon KE. Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. Annu Rev Clin Psychol 2006; 2: 111-133. (Pubitemid 43799801)
49. Glover G, Webb M, Evison F. Improving Access to Psychological Therapies. A review of the progress made by sites in the first rollout year London: North East Public Health Observatory, 2010.
50. ten Have M, de Graaf R, Ormel J, Vilagut G, Kovess V, Alonso J. Are attitudes towards mental health help-seeking associated with service use? Results from the European Study of Epidemiology of Mental Disorders. Soc Psychiatry Psychiatr Epidemiol 2012; 45: 153-163.
51. Institut National de la Statistique et des Études Économiques. [Age pyramid on 1 January 2011] (in French) Paris: INSEE, 2011.
52. th 2013)
53. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12 Suppl 1: 1-27.
54. Sobocki P, Jonsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ 2006; 9: 87-98. (Pubitemid 44018376)
55. Souetre E, Lozet H, Cimarosti I, Martin P, Chignon JM, Ades J, Tignol J, Darcourt G. Cost of anxiety disorders: impact of comorbidity. J Psychosom Res 1994; 38 (Suppl 1): 151-160.
56. Hoyer J, Gloster AT. Psychotherapy for generalized anxiety disorder: don't worry, it works! Psychiatr Clin North Am 2009; 32: 629-640.
57. Clark DM, Layard R, Smithies R, Richards DA, Suckling R, Wright B. Improving access to psychological therapy: Initial evaluation of two UK demonstration sites. Behav Res Ther 2009; 47: 910-920.
58. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 1998; 49: 59-72. (Pubitemid 28139098)
59. Kovess V, Sapinho D, Briffault X, Villamaux M. [Psychotherapeutic practices in France: results of a professional-based health insurance participant survey] (in French) Encephale 2007; 33: 65-74.
60. Haute Autorité de Santé (HAS) : [Les recommandations du jury de la réunion de consensus sur la vaccination contre le virus de l'hépatite B (VHB)] (in French). Haute Autorité de Santé, 2003.
61. Haute Autorité de Santé (HAS): [Recommandations professionnelles : Comment mieux informer les femmes enceintes?] (in French). Haute Autorité de Santé, 2005.
62. Haute Autorité de Santé (HAS): [Prise en charge des complications évolutives d'un épisode dépressif caractérisé de l'adulte in Recommandations. Pour La Pratique Clinique] (in French). Haute autorité de Santé, Service des recommandations et références professionnelles, Service évaluation médico-économique et santé publique. Paris, 2007.
63. Haute Autorité de Santé (HAS): [Guide mé thodologique: Choix méthodologiques pour l'évaluation économique à la HAS] (in French). Haute Autorité de Santé, 2011.
64. Mukuria C, Brazier J, Barkham M, Connell J, Hardy G, Hutten R, Saxon D, Dent-Brown K, Parry G. Cost-effectiveness of an Improving Access to Psychological Therapies service. Br J Psychiatry 2013; 202: 220-227.
65. Organisation for Economic Co-operation and Development. Private Health Insurance in OECD Countries. OECD Observer 2004; 9: 1-8.
66. Cuijpers P, Andersson G, Donker T, van Straten A. Psychological treatment of depression: Results of a series of meta-analyses. Nord J Psychiatry 2011; 65: 354-364.
67. Ioannidis JP. Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philos Ethics Humanit Med 2008 3: 14.
68. Sobocki P, Ekman M, Agren H, Runeson B, Jonsson B. The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression. Int J Clin Pract 2006; 60: 791-798. (Pubitemid 43881154)
69. Prince M, Patel V, Saxena S, Maj M, Maselko M, Phillips M, Rahman A. No health without mental health. Lancet 2007; 370: 859-877. (Pubitemid 47371145)
70. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005; 19: 113-122. (Pubitemid 40312625)
71. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res 2003; 12: 22-33. (Pubitemid 36675445)
72. th 2013).
73. Simon GE, Grothaus L, Durham ML, VonKorff M, Pabiniak C. Impact of visit copayments on outpatient mental health utilization by members of a health maintenance organization. Am J Psychiatry 1996; 153: 331-338. (Pubitemid 26074707)
74. Alegria M, Bijl RV, Lin E, Walters EE, Kessler RC. Income differences in persons seeking outpatient treatment for mental disorders: a comparison of the United States with Ontario and The Netherlands. Arch Gen Psychiatry 2000; 57: 383-391. (Pubitemid 30202330)
75. Bourgueil Y, Marek A, Mousques J. [Practice, role and position of nurses in primary care in six European countries, in Ontario and in Quebec], Recherche en soins infirmiers 2008; 93: 94-105.